Innovita Biological Technology Balance Sheet Health
Financial Health criteria checks 6/6
Innovita Biological Technology has a total shareholder equity of CN¥2.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.2B and CN¥126.4M respectively. Innovita Biological Technology's EBIT is CN¥334.3M making its interest coverage ratio -11.6. It has cash and short-term investments of CN¥1.9B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -11.6x |
| Cash | CN¥1.86b |
| Equity | CN¥2.04b |
| Total liabilities | CN¥126.42m |
| Total assets | CN¥2.17b |
Recent financial health updates
No updates
Recent updates
We Think Innovita Biological Technology's (SHSE:688253) Robust Earnings Are Conservative
Nov 01
Investors Could Be Concerned With Innovita Biological Technology's (SHSE:688253) Returns On Capital
Sep 28Statutory Profit Doesn't Reflect How Good Innovita Biological Technology's (SHSE:688253) Earnings Are
Apr 22There's Reason For Concern Over Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Massive 25% Price Jump
Mar 20Financial Position Analysis
Short Term Liabilities: 688253's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥120.3M).
Long Term Liabilities: 688253's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥6.1M).
Debt to Equity History and Analysis
Debt Level: 688253 is debt free.
Reducing Debt: 688253 has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.
Debt Coverage: 688253 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688253 has no debt, therefore coverage of interest payments is not a concern.